Geltech

Gelteq is a clinical-stage pharmaceutical and consumer health company specializing in the development of gel-based oral delivery systems. The company's proprietary platform technology transforms liquid or solid medications and nutrients into a gel format, designed to improve swallowability for patients with dysphagia, mask unpleasant tastes, and potentially enhance bioavailability. Gelteq's pipeline includes clinical programs for Type 2 diabetes and hypoglycemia, alongside a range of commercialized nutraceutical products for sports, hydration, and pet health. Headquartered in Australia, the company focuses on providing patient-centric alternatives to traditional pills and capsules across multiple therapeutic areas.